Unibest
← Back to patent-cliff list

CAS 143900-44-1

(S)-tert-butyl 3-hydroxypiperidine-1-carboxylate(3S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine

Codes: IBRT-006, (VI)461018-5-a, (I)461018-6-a, (V)461018-8-a, (IIIa)461018-11-a, (I)461018-12-a, (I)461018-20-a, (I)461018-21-a, (X)461018-26-a, (I)461018-32-a

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

IbrutinibOptimised routesteps: 4total yield: /

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Sitetert-butyl (S)-3-hydroxypiperidine -1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.